Pill Connect Company

Pill Connect is a company specializing in designing, developing, and manufacturing innovative medical devices for dispensing solid oral dose medication. The application provided by the company enables real-time feedback to manage adherence with intelligent reminders. Pill Connect innovative dosing system allows remote monitoring of each dose of medicines in real-time, supporting patient adherence with digital dispensing controlled by their dose schedule, and empowering patients with their data to show adherence trends and progress. The app learns when non-adherence is more likely and creates personalized reminders to combat it. Pill Connect and AARDEX Group start partnering in 2021 to empower patient adherence. The collaboration will link AARDEX’s proprietary Medication Event Monitoring System (MEMS) with Pill Connect’s add-on solutions for drug delivery devices. The combined system has significant potential to influence patients’ adherence performance radically.

Total Funding: £1 400 000
Headquarters: Manchester, United Kingdom
Funding Status: Early Stage Venture
Employee Number: 1-10
Estimated Revenue: £780 000 - £7 800 000
Last Funding Type: Series A
Last Funding Date: 09-19-2017
Investors Number: 3
Founded Date: 2013
Industry: PharmTech